Travel
Investment opportunities already packed for you. This carefully curated collection of travel stocks represents companies poised to capitalize on the industry's post-pandemic revival. Selected by professional analysts for their recovery potential and growth opportunities.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
After navigating turbulent times, the travel industry is poised for significant recovery. With increasing demand for exploration and new experiences worldwide, these companies are positioned to benefit from the projected industry growth of over 4% annually and the human desire to connect through travel.
What You Need to Know
This collection spans the full travel ecosystem: airlines, cruise lines, hotels, booking platforms, and entertainment. The global travel market is expected to reach $1,016 billion by 2027, with air travel returning to pre-pandemic levels by 2024 and the cruise industry potentially doubling in size from 2021 to 2026.
Why These Stocks
These 25 companies represent established leaders driving the travel industry's comeback. From accommodation giants like Marriott and Airbnb to cruise operators like Royal Caribbean, and airlines like Delta, they're creating memorable travel experiences while potentially generating significant value for investors.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+16.14%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 16.14% over the next year.
Stocks Rated Buy by Analysts
19 of 24 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.2% return last month.
Why You'll Want to Watch These Stocks
Post-Pandemic Rebound Potential
The travel industry is making an impressive comeback with projected market growth to $1,016 billion by 2027. These stocks could benefit enormously as travel returns to—and potentially surpasses—pre-pandemic levels.
Cruise Industry Set to Double
Major cruise operators like Royal Caribbean, Carnival, and Norwegian are positioned for an extraordinary recovery, with the global cruise market expected to grow from $18.8 billion to $39.6 billion between 2021 and 2026.
Air Travel Taking Off Again
Airlines are seeing passenger numbers climb toward pre-pandemic levels, expected to fully recover by 2024. This resurgence presents a potentially valuable opportunity for investors looking to ride the wave of travel's comeback story.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Beyond The App Store: Europe's New Rules
Following regulatory pressure from the European Union, Google has revised its Play Store rules to permit alternative payment systems. This change creates a new investment opportunity in companies poised to benefit from a more open mobile app ecosystem.
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Frequently Asked Questions
Everything you need to know about the product and billing.